Clinical trial
Cancer of the Pancreas Screening Study (CAPS 3)
NCT00438906 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00438906 |
|---|---|
| Title | Cancer of the Pancreas Screening Study (CAPS 3) |
| Official title | Screening for Early Pancreatic Neoplasia |
| Acronym | CAPS 3 |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Lustgarten Foundation National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Pancreatic Neoplasm, Peutz-Jeghers Syndrome |
| Intervention type | Drug, Procedure |
| Interventions | Biopsy, Fine Needle Aspiration (FNA), Secretin (human synthetic) - ChiRhoClin |
| Enrollment | 200 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Feb 22, 2007 |
| Last update posted | Jun 18, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: